valsartan has been researched along with allisartan isoproxil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; He, X; Wu, J | 1 |
1 review(s) available for valsartan and allisartan isoproxil
Article | Year |
---|---|
Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
Topics: Cost-Benefit Analysis; Drug Combinations; Essential Hypertension; Humans; Valsartan | 2022 |